Sean Duffy Sells 12,942 Shares of Omada Health (NASDAQ:OMDA) Stock

Key Points

• CEO Sean Duffy sold 12,942 Omada Health shares at an average price of $24.81, generating approximately $321,091. He retains 411,861 shares, and the sale reduced his ownership by 3.05%.
• Omada Health reported quarterly EPS of $0.08, beating the consensus estimate of a $0.02 loss, while revenue of $87.83 million exceeded expectations of $80.93 million.
• Analysts maintain a favorable outlook, with 11 Buy ratings, two Holds and one Sell; the stock has a consensus “Moderate Buy” rating and a $25.67 average price target.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 12,942 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $24.81, for a total value of $321,091.02. Following the transaction, the chief executive officer owned 411,861 shares of the company's stock, valued at approximately $10,218,271.41. This trade represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Omada Health Price Performance

Shares of NASDAQ:OMDA traded down $0.98 during midday trading on Tuesday, reaching $24.01. The company had a trading volume of 1,906,414 shares, compared to its average volume of 1,272,868. The stock has a market capitalization of $1.43 billion, a P/E ratio of 480.20 and a beta of 1.73. The stock's fifty day moving average price is $20.49 and its 200-day moving average price is $16.26. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92.

Omada Health (NASDAQ:OMDA - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.10. The firm had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.67%. As a group, sell-side analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Needham & Company LLC reiterated a "buy" rating and issued a $28.00 price target on shares of Omada Health in a research note on Friday, May 8th. Citigroup reaffirmed an "outperform" rating on shares of Omada Health in a report on Monday, July 20th. Barclays lifted their target price on Omada Health from $20.00 to $25.00 and gave the stock an "overweight" rating in a research report on Monday, August 3rd. Canaccord Genuity Group boosted their price target on Omada Health from $24.00 to $28.00 and gave the company a "buy" rating in a report on Tuesday, July 21st. Finally, Citizens Jmp upped their price target on Omada Health from $21.00 to $27.00 and gave the company a "market outperform" rating in a research report on Monday, July 20th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $25.67.

Institutional Investors Weigh In On Omada Health

Institutional investors and hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. acquired a new position in Omada Health in the second quarter valued at approximately $32,000. Quarry LP acquired a new stake in shares of Omada Health during the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. bought a new stake in shares of Omada Health in the 4th quarter worth approximately $32,000. Inlight Wealth Management LLC acquired a new position in Omada Health during the 4th quarter valued at approximately $45,000. Finally, Versant Capital Management Inc boosted its position in Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock valued at $66,000 after purchasing an additional 2,283 shares during the period.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source